Current role of 18F-FDG-PET in the differential diagnosis of the main forms of dementia

被引:3
|
作者
Guillen, Edgar F. [1 ]
Rosales, Juan J. [2 ]
Lisei, Dario [3 ]
Grisanti, Fabiana [2 ]
Riverol, Mario [4 ]
Arbizu, Javier [2 ]
机构
[1] Clin Univ Navarra, Dept Nucl Med, Madrid, Spain
[2] Clin Univ Navarra, Dept Nucl Med, Pamplona, Spain
[3] Hosp Univ Cent Asturias, Dept Nucl Med, Oviedo, Spain
[4] Clin Univ Navarra, Dept Neurol, Pamplona, Spain
关键词
18F-FDG; PET; Differential diagnosis; Mild cognitive impairment; Alzheimer's disease; Frontotemporal lobar degeneration; Primary progressive aphasia; Vascular dementia; Pseudodementia; MILD COGNITIVE IMPAIRMENT; VARIANT FRONTOTEMPORAL DEMENTIA; PRIMARY PROGRESSIVE APHASIA; ALZHEIMERS ASSOCIATION WORKGROUPS; POSITRON-EMISSION-TOMOGRAPHY; POSTERIOR CORTICAL ATROPHY; FDG-PET; BEHAVIORAL VARIANT; GLUCOSE-METABOLISM; VASCULAR DEMENTIA;
D O I
10.1007/s40336-020-00366-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose We aim to present and critically evaluate the use of FDG-PET in the differential diagnosis between dementing conditions including Alzheimer disease (AD), frontotemporal dementia (FTD) and its variants, vascular dementia (VaD) and pseudodepressive dementia. Methods This review is based on the available consensus recommendations for the use of FDG-PET and current clinical diagnostic criteria. In addition, we updated these reviews with relevant publications in the field after conducting a literature search during the last 5 years through predefined keyword strings relating to the specific terms related to the diseases covered in this review and a common part ('FDG-PET'). Results Neurodegenerative disease are complex groups of several forms of dementia and their clinical diagnostic criteria are progressively incorporating imaging biomarkers as a supporting tool. The role of FDG-PET is currently increasing as part of the clinical practice supporting the clinical diagnosis of AD (at both mild cognitive impairment-MCI-and early dementia stages), FTD and its variants, as well as VaD and pseudodepressive dementia. The pattern of AD is well defined and its negative predicted value may help the differential diagnosis when comorbidities like vascular disease or depression are present. However, the formal evidence supporting the use of FDG-PET is reasonable for MCI due to AD, and the differential diagnosis between FTD and AD, but lacking for the remaining clinical uses. Interestingly, the evidence provided during the last years reinforces these recommendations and gives additional clues about the usefulness of semiquantitative methods in addition to visual reading. Conclusion The large experience accumulated using FDG-PET for the differential diagnosis of the main conditions with dementia has been translated into more formal evidence to support its clinical use. Although FDG-PET form currently part of the clinical practice in many countries, there is still a lack of studies using standardized analysis that confirm specific patterns at individual level.
引用
收藏
页码:127 / 140
页数:14
相关论文
共 50 条
  • [31] Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic review
    Singnurkar, Amit
    Poon, Raymond
    Metser, Ur
    ANNALS OF NUCLEAR MEDICINE, 2017, 31 (05) : 366 - 378
  • [32] The Role of 18F-FDG-PET/TC in the Diagnosis of Autoimmune Encephalitis in patients with Paraneoplastic Syndrome
    Baquero, M.
    Mantilla, J. Ardila
    De la Santa, J. Atance Garcia
    Pastor, J. Montalva
    Cepeda, M. Casallas
    Fernandez, I. Gomez
    Hualde, A. Mari
    Rincon, J. Orcajo
    Farto, J. Alonso
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S561 - S561
  • [33] 18F-FDG-PET/CT in myelofibrosis
    Behrendt, F. F.
    Krohn, T.
    Palmowski, M.
    Mottaghy, F. M.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2011, 50 (06): : N66 - N67
  • [34] Role of 18F-FDG-PET and amyloid-PET imaging on patient management in mild cognitive impairment or dementia
    Gamez-Cenzano, C.
    Rodriguez-Bel, L.
    Gascon-Bayarri, J.
    Rene-Ramirez, R.
    Campdelacreu-Fumado, J.
    Turon-Sans, J.
    Soriano-Mas, C.
    Vercher-Conejero, J.
    Gracia-Sanchez, L.
    Llinares-Tello, E.
    Pons-Escoda, A.
    Majos-Torro, C.
    Aguilera-Grijalvo, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S117 - S117
  • [35] 18F-FDG-PET/CT and FUO
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (02) : 19N - 19N
  • [36] 18F-FDG-PET/CT in Prostate Cancer: is there any role?
    Gogou, L.
    Kehagias, D.
    Nikaki, A.
    Filippi, V.
    Vlachou, F.
    Efthimiadou, R.
    Gogos, K.
    Papoutsis, V.
    Andreou, I.
    Prassopoulos, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S276 - S277
  • [37] 18F-FDG-PET in inflammatory disease
    Otto, D
    Börner, AR
    Weckesser, E
    Hofmann, M
    Petrich, T
    Knapp, WH
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1061 - 1061
  • [38] Colorectal cancer: prognostic role of 18F-FDG-PET/CT
    Grassetto, Gaia
    Capirci, Carlo
    Marzola, Maria Cristina
    Rampin, Lucia
    Chondrogiannis, Sotirios
    Musto, Alessandra
    Crepaldi, Giorgio
    Minicozzi, Anna Maria
    Massaro, Arianna
    Rubello, Domenico
    ABDOMINAL IMAGING, 2012, 37 (04): : 575 - 579
  • [39] Colorectal cancer: prognostic role of 18F-FDG-PET/CT
    Gaia Grassetto
    Carlo Capirci
    Maria Cristina Marzola
    Lucia Rampin
    Sotirios Chondrogiannis
    Alessandra Musto
    Giorgio Crepaldi
    Anna Maria Minicozzi
    Arianna Massaro
    Domenico Rubello
    Abdominal Imaging, 2012, 37 : 575 - 579
  • [40] Oesophageal tumour progression between the diagnostic 18F-FDG-PET and the 18F-FDG-PET for radiotherapy treatment planning
    Muijs, Christina T.
    Pruim, Jan
    Beukema, Jannet C.
    Berveling, Maaike J.
    Plukker, John Th.
    Langendijk, Johannes A.
    RADIOTHERAPY AND ONCOLOGY, 2013, 106 (03) : 283 - 287